OHSU Innovates 2021 Impact Report highlights many of the successes and positive impacts over the past year
OHSU expedites promising new technologies to tackle COVID-19
2021 Biomedical Innovation Program awards announced
Latest news
Winners of Biomedical Innovation Program awards address significant clinical problems
January 4
OHSU startup ProMedix selected to participate in mHUB Accelerator program for medical devices
November 10
AstraZeneca accepts six new research projects from Knight Cancer Institute
October 29
OHSU Startup Luciole Pharmaceuticals announces collaboration
October 6
OHSU startup awarded $4.3M in grants for cancer research
September 21
We welcome and appreciate the collaborative nature of organizations that want to be a part of the ongoing innovative and entrepreneurial efforts at OHSU. Thank you to our sponsors!
Featured technology
Nanoparticle ultrasound contrast agents
Technology #2823
Adem Yildirim Ph.D. and colleagues at the Knight Cancer Institute Cancer Early Detection Advanced Research (CEDAR) center have developed novel nanoparticle contrast agents, that are small enough to accumulate within tumors. These nanoparticle contrast agents can potentially be used with ultrasound for diagnostic and therapeutic applications to improve tumor detection and cancer patient care.
Upcoming events
OHSU Technology Transfer Virtual Office Hours
Every Friday from 9-10 am PST (see O2 calendar for Webex link).
NCATS SBIR/STTR Panel Discussion
January 13
Accelerate Biotech + Digital Health Virtual Happy Hour
January 13
Lunch & Learn: Center for Experimental Therapeutics -Translating Discoveries from Lab to Clinic
January 19
Pitching 101: How to Present Your Startups and Technology Innovation to Potential Funders
January 19
Pitch Oregon
February 11
Join our mailing list
Subscribe to the OHSU Innovation and Commercialization mailing list to receive news, events and updates involving OHSU innovations.